Sign In
Buy CG
The Carlyle Group L.P Earnings Calls
| Release date | Oct 31, 2025 |
| EPS estimate | $1.02 |
| EPS actual | $0.96 |
| EPS Surprise | -5.88% |
| Revenue estimate | 989.936M |
| Revenue actual | 782.75M |
| Revenue Surprise | -20.93% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.89 |
| EPS actual | $0.91 |
| EPS Surprise | 2.48% |
| Revenue estimate | 904.673M |
| Revenue actual | 1.573B |
| Revenue Surprise | 73.86% |
| Release date | May 09, 2025 |
| EPS estimate | $0.96 |
| EPS actual | $1.14 |
| EPS Surprise | 19.37% |
| Revenue estimate | 992.388M |
| Revenue actual | 807.8M |
| Revenue Surprise | -18.60% |
| Release date | Feb 10, 2025 |
| EPS estimate | $0.95 |
| EPS actual | $0.92 |
| EPS Surprise | -3.06% |
| Revenue estimate | 961.563M |
| Revenue actual | 927M |
| Revenue Surprise | -3.59% |
Last 4 Quarters for The Carlyle Group L.P
Below you can see how CG performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 10, 2025 |
| Price on release | $51.48 |
| EPS estimate | $0.95 |
| EPS actual | $0.92 |
| EPS surprise | -3.06% |
| Date | Price |
|---|---|
| Feb 04, 2025 | $52.18 |
| Feb 05, 2025 | $52.58 |
| Feb 06, 2025 | $52.58 |
| Feb 07, 2025 | $52.49 |
| Feb 10, 2025 | $51.48 |
| Feb 11, 2025 | $49.58 |
| Feb 12, 2025 | $49.95 |
| Feb 13, 2025 | $51.03 |
| Feb 14, 2025 | $51.77 |
| 4 days before | -1.34% |
| 4 days after | 0.563% |
| On release day | -3.69% |
| Change in period | -0.786% |
| Release date | May 09, 2025 |
| Price on release | $42.04 |
| EPS estimate | $0.96 |
| EPS actual | $1.14 |
| EPS surprise | 19.37% |
| Date | Price |
|---|---|
| May 05, 2025 | $40.50 |
| May 06, 2025 | $39.97 |
| May 07, 2025 | $39.95 |
| May 08, 2025 | $41.26 |
| May 09, 2025 | $42.04 |
| May 12, 2025 | $45.62 |
| May 13, 2025 | $45.97 |
| May 14, 2025 | $47.05 |
| May 15, 2025 | $47.00 |
| 4 days before | 3.80% |
| 4 days after | 11.80% |
| On release day | 8.52% |
| Change in period | 16.05% |
| Release date | Aug 05, 2025 |
| Price on release | $60.10 |
| EPS estimate | $0.89 |
| EPS actual | $0.91 |
| EPS surprise | 2.48% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $61.97 |
| Jul 31, 2025 | $60.66 |
| Aug 01, 2025 | $58.71 |
| Aug 04, 2025 | $60.43 |
| Aug 05, 2025 | $60.10 |
| Aug 06, 2025 | $62.90 |
| Aug 07, 2025 | $61.57 |
| Aug 08, 2025 | $62.23 |
| Aug 11, 2025 | $62.40 |
| 4 days before | -3.02% |
| 4 days after | 3.83% |
| On release day | 4.66% |
| Change in period | 0.694% |
| Release date | Oct 31, 2025 |
| Price on release | $53.32 |
| EPS estimate | $1.02 |
| EPS actual | $0.96 |
| EPS surprise | -5.88% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $58.22 |
| Oct 28, 2025 | $57.71 |
| Oct 29, 2025 | $57.59 |
| Oct 30, 2025 | $56.57 |
| Oct 31, 2025 | $53.32 |
| Nov 03, 2025 | $51.81 |
| Nov 04, 2025 | $51.16 |
| Nov 05, 2025 | $52.05 |
| Nov 06, 2025 | $52.49 |
| 4 days before | -8.42% |
| 4 days after | -1.56% |
| On release day | -2.83% |
| Change in period | -9.84% |
The Carlyle Group L.P Earnings Call Transcript Summary of Q3 2025
Carlyle reported a strong Q3 2025 with continued organic growth across fee-related earnings (FRE), assets under management (AUM) and fundraising momentum. Key operating highlights: Q3 FRE of $312M and $946M YTD (up 16%); record AUM of $474B (up 7% YTD); $17B of inflows in Q3 and nearly $60B over the last 12 months. Major growth drivers were Global Credit, Carlyle AlpInvest (notably a $20B secondaries fund) and Global Wealth (evergreen inflows reached $3B this quarter). Global Credit and AlpInvest now represent a much larger share of FRE (about 55% combined). Carlyle emphasized strong realization activity (returned ~$19B in private equity over the last year, plus signed transactions) and a robust pipeline heading into Q4 and 2026 (including a EUR7.7B BASF carve-out and Medline IPO filing). Balance sheet actions included $800M 10-year notes at 5% and ~$200M of share repurchases this quarter (near-term repurchase program nearing completion). Management reiterated confidence in exceeding the upgraded full-year targets (FRE growth ~10%+ and inflows toward $50B), highlighted durable credit/insurance demand and accelerated wealth distribution initiatives. Investors should note the firm’s shift toward recurring-fee, credit and solutions businesses, continued margin expansion, and active capital allocation balancing reinvestment, buybacks and shareholder returns.
